A model for the study of experimentally induced temporomandibular arthritis in rats: The effect of human recombinant interleukin-1α on neuropeptide-like immunoreactivity

Journal of Orofacial Pain

Volumn 10, Issue 1, 1996, Pages 9-14

  Carleson, Joakim ^a   Alstergren, P ^b   Appelgren, Anna ^b   Appelgren, Björn ^b   Kopp, S ^b   Theodorsson, Elvar ^c   Lundeberg, Thomas ^b,c  

^a School of Dentistry   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arthritis; Interleukin; Neuropeptide; Rats; Temporomandibular joint

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; INTERLEUKIN 1; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE Y; RECOMBINANT PROTEIN; SUBSTANCE P;

ANIMAL; ARTHRITIS; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; MALE; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER;

ANIMALS; ARTHRITIS; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; INTERLEUKIN-1; MALE; NEUROIMMUNOMODULATION; NEUROKININ A; NEUROPEPTIDE Y; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SUBSTANCE P; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 0030338490     PISSN: 10646655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Dinarello CA. Interleukin-1. Dig Dis Sci 1988;33:25-35.
2. Besedovsky H, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986;233:652-654.
3. Berkenbosch F, van Oers J, del Rey A, Tilders F, Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987;238:524-526.
4. Wahl SM, Altman LC, Rosenstreich DL. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids. J Immunol 1975;115:476-481.
5. Gillis S, Crabtree GR, Smith KA. Glucocorticoid-induced inhibition of T cell factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 1979;123:1624-1631.
6. Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev 1982;65:133-155.
7. McGills JP, Organist ML, Payan DG. Substance P and immunoregulation. Fed Proc 1987;46:196-199.
8. Scicchitano R, Biennenstock J, Stanisz AM. In vivo immunomodulation by the neuropeptide substance P. Immunology 1988;63:733-735.
9. Casini A, Geppetti P, Maggi CA, Surrenti C. Effects of calcitonin gene-related peptide (CGRP), neurokinin A and neurokinin A (4-10) on the mitogenic response of human peripheral blood mononuclear cells. Naunyn Schmiedebergs Arch Pharmacol 1989;339:354-358.
10. Nong YH, Titus RG, Ribeiro JMC, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 1989;143:45-49.
11. Umeda Y, Takamiya M, Yoshizaki H, Arisawa M. Inhibition of mitogen-stimulated T lymphocytes proliferation by calcitonin gene-related peptide. Biochem Biophys Res Commun 1988;154:227-235.
12. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1987;235:893-895.
13. Kimball ES, Persico FJ, Vaught JL. Substance P, neurokinin A and neurokinin B induce generation of IL-1 like activity in P338D1 cells. Immunol 1988;141:3564-3569.
14. Hart RP, Shadiack AM, Jonakait GM. Substance P gene expression is regulated by interleukin-1 in cultured sympathetic ganglia. J Neurosci Res 1991;29:282-291.
15. Jonakait MG, Schotland S, Hart RP. Effects of lym-phokines on substance P in injured ganglia of the peripheral nervous system. Ann NY Acad Sci 1991;632:19-30.
16. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 1979;310:175-183.
17. Gamse R, Posch M, Saria A, Jancso G. Several mediators appear to interact in neurogenic inflammation. Acta Physiol Hung 1987;69:343-354.
18. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985;313:54-56.
19. Lundberg JM, Franco-Cereceda A, Hua X, Hökfelt T, Fischer JA. Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol 1985;108: 315-319.
20. Saria A, Gamse R, Petermann J, Fischer JA, Theodorsson-Norheim E, Lundberg JM. Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices. Neurosci Lett 1986;63:310-314.
21. 2+ currents in rat sensory neurons. J Neurosci 1988;8:2438-2446.
22. Pernow J, Lundberg JM, Kaijser L. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life Sci 1987;40:47-54.
23. Bileviciute I, Lundeberg T, Ekblom A, Theodorsson E. Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci Lett 1993;153:37-40.
24. Bileviciute I, Lundeberg T, Ekblom A, Theodorsson E. Substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity (-LI) in rat knee joint synovial fluid during acute monoarthritis is not correlated with concentrations of neuropeptide-LI in cerebrospinal fluid and plasma. Neurosci Lett 1994;167:145-148.
25. Theodorsson-Norheim E, Hemsen A, Brodin E, Lundberg JNI. Sample handling techniques when analyzing regulatory peptides. Life Sci 1987;41:845-848.
26. Theodorsson-Norheim E, Hemsen A, Lundberg JM. Radioimmunoassay for neuropeptide Y (NPY): Chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand J Clin Lab Invest 1985;45:355-365.
27. Conlon PJ, Grabstein KH, Alpert A, Prickett KS, Kopp TP, Gillis S. Localization of human mononuclear cell interleukin 1. J Immunol 1987;139:98-102.
28. Barkley DE, Fledmann M, Maini RN. Cells with dendritic morphology and bright interleukin-1 staining circulate in the blood of patients with rheumatoid arthritis. Clin Exp Immunol 1990;80:25-31.
29. Payan DG. Substance P: Modulator of neuroendocrine-immune function. Hosp Pract 1989;24:67-80.
30. Nouri AME, Panayi GS, Goodman SM. Cytokines and the chronic inflammation of rheumatic disease. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 1984;55:295-302.
31. Johnson WJ, Muirhead KA, Meunier PC, Votta BJ, Schnitt TC, DiMartino MJ, Hanna N. Macrophage activation in rat models of inflammation and arthritis. Arthritis Rheum 1986;20:1122-1130.
32. Goto M, Sasano M, Yamanaka H, Miyasaka N, Kamatani N, Inoue K, et al. Spontaneous production of an interleukin-1 like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest 1987;80:786-796.
33. Dalton BJ, Connor JR, Johnson WJ. Interleukin-1 induces interleukin-1 and interleukin-1ß gene expression in synovial fibroblasts and peripheral blood monocytes. Arthritis Rheum 1988;32:279-287.
34. Erdös EG, Skidgel RA. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989;3:145-151.
35. Pierart ME, Najdovski T, Appelboom TE, Deschodt-Lanckman MM. Effect of human endopeptidase 24.11 (enkephalinase) on IL-1 induced thymocte proliferation activity. J Immunol 1988;140:3808-3811.
36. O'Byrne EM, Blancuzzi V, Wilson DE, Wong M, Jeng AY. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum 1990;33:1023-1028.
37. Yu L-C, Hansson P, Brodda-Jansen G, Theodorsson E, Lundeberg T. Intrathecal CGRP8-37 results in a bilateral increase in hindpaw withdrawal latency in rats with experimentally induced unilateral inflammation. Br J Pharmacol 1996;(in press).
38. Nanayama T, Kuraishi Y, Ohno H, Satoh M. Capsaicin-induced release of calcitonin gene-related peptide from dorsal horn slice is enhanced in adjuvant arthritic rats. Neurosci Res 1989;6:569-572.
39. Cruwys SC, Kidd BL, Mapp PI, Walsh DA, Blake DR. The effects of calcitonin gene-related peptide on formation of intra-articular oedema by inflammatory mediators. Br J Pharmacol 1992;107:116-119.
40. Cruwys SC, Garrett NE, Perkins MN, Blake DR, Kidd BL. The role of bradykinin b1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen induced arthritis. Br J Pharmacol 1994;113:940-944.
41. Denko CW, Petricevic M. Sympathetic or reflex footpad swelling due to crystal induced inflammation in the opposite foot. Inflammation 1978;3:81-86.
42. Levine JD, Dardick SJ, Roizen MF, Basbaum AI, Scipio E. Reflex neurogenic inflammation. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. J Neurosci 1985;5:1380-1386.
43. Mapp PI, Walsh DA, Cruwys SC, Kidd BL, Polak JM, Blake DR. Localization of neutral endopeptidase to the human synovium. J Rheumatol 1992;19:1838-1844.
44. Mapp PI, Terengi G, Walsh DA, Chen ST, Cruwys SC, Garrett N, et al. Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience 1993;57:1091-1096.
45. 2-adrenoceptors. Neuroscience 1990;34:521-523.
46. Alstergren P, Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Arch Oral Biol 1995;40:127-135.
47. Alstergren P, Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Intraarticular glucocorticoid treatment of temporomandibular joint arthritis with consideration to effects on joint fluid content of neuropeptide Y. Acta Odontol Scand 1995;53:12-21.
48. Appelgren A, Appelgren B, Eriksson S, Kopp S, Lundeberg T, Nylander M, Theodorsson E. Neuropeptides in temporomandibular joints with rheumatoid arthritis. A clinical study. Scand J Dent Res 1991;99:519-521.
49. Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Relation between the intraarticular temperature of the temporomandibular joint and the presence of neuropeptide Y-like immunoreactivity in the joint fluid. Acta Odontol Scand 1993;51:1-8.
50. Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special consideration to rheumatoid arthritis. J Orofacial Pain 1995;9:215-225.